Monashee Investment Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-95,000
| Closed | -$1.87M | – | 71 |
|
|
2022
Q3 | $1.87M | Sell |
95,000
-145,000
| -60% | -$2.85M | 0.69% | 24 |
|
|
2022
Q2 | $4.2M | Buy |
240,000
+150,000
| +167% | +$2.62M | 1.53% | 2 |
|
|
2022
Q1 | $1.47M | Sell |
90,000
-5,000
| -5% | -$81.8K | 0.43% | 22 |
|
|
2021
Q4 | $1.55M | Buy |
+95,000
| New | +$1.55M | 0.38% | 33 |
|
|
2021
Q1 | – | Sell |
-272,949
| Closed | -$4.33M | – | 454 |
|
|
2020
Q4 | $4.33M | Buy |
+272,949
| New | +$4.33M | 0.57% | 37 |
|